TY - JOUR T1 - Effect of the trajectory of exertional breathlessness on symptom recall and prediction: a randomized controlled trial JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2020.1832 VL - 56 IS - suppl 64 SP - 1832 AU - Viktor Elmberg AU - Magnus Ekström Y1 - 2020/09/07 UR - http://erj.ersjournals.com/content/56/suppl_64/1832.abstract N2 - Background: Breathlessness is a major cause of physical limitation. Recalled breathlessness intensity may differ from experienced intensity and be influenced by the intensity trajectory including the ‘peak-end rule’. The primary aim was to test if adding two minutes of low intensity exercise at the end of an exercise test would change the recalled breathlessness. Secondary aims included to analyse the impact of the peak and end exertional breathlessness intensity on breathlessness recall.Methods: Randomized controlled trial of 92 adults referred for exercise testing who were randomized (1:1), at test end, to 2 minutes of additional low intensity exercise (intervention; n=47) or stopping at peak exertion (control; n=45). Experienced breathlessness during the test and recalled intensity (30 min after the test) was assessed using the Borg CR10 scale.Results: Participants were aged a mean 59 years; 61% men; 79% reported a mMRC ≥1. There was no between-group difference in recalled breathlessness intensity, 5.51 ([95% CI] 5.00 to 6.01) vs. 5.73 (5.27 to 6.20; p = 0.52) in controls, even though the intervention group had a significantly lower end breathlessness (mean difference 0.96;0.24 to 1.67; p=0.009).. Recalled exertional breathlessness was most strongly related to peak breathlessness (r2=0.43). In joint analysis, end breathlessness did not add any additional explanatory value to that of peak.Conclusion: Adding an episode of two minutes of lower exercise and breathlessness intensity at the end of an exercise test did not affect symptom recall, which was most strongly related to peak breathlessness.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 1832.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -